438
report
Key Trends in Health at Milken Institute Global Conference 2023
The 26th annual Milken Institute Global Conference convened the best minds in the world to tackle i
ts most urgent challenges and realize its most exciting opportunities.
+ Read More
report
Mapping the Journey: Building a Mutual Understanding for Health Equity in Clinical Research
If the objective of biomedical research is to spur innovation to create healthier communities, exte
nd life, and more effectively treat or cure disease, then persistent inequities run counter to that goal and create unnecessary barriers to health and wel
+ Read More
report
Community-Based Infrastructure for Inclusive Research: Engaging the Private Sector
Clinical trial networks, as evidenced during the COVID-19 pandemic, really are “national critical i
nfrastructure.” The pandemic revealed prominent gaps and stark differences in health outcomes across various populations.
+ Read More
report
Estimating Long-term Economic Returns of NIH Funding on Output in the Biosciences
Advances in biomedical research have spurred dramatic improvements in both human and economic healt
h.
+ Read More
report
Building Community-Based Infrastructure for Inclusive Research: Lessons from the Pandemic for Federal Action
COVID-19 has focused the public’s attention on the racial and ethnic disparities in health outcomes
, unequal access to health care, and some communities’ lack of trust and participation in medical research.
+ Read More
report
Protecting the Progress for Biomedical Innovation: A Post-Pandemic Scorecard
Since early in the COVID-19 pandemic, FasterCures has been committed to capturing lessons learned a
nd opportunities to improve the biomedical research ecosystem.
+ Read More
report
Coalition-Building between the US and China on Women’s Cancer Detection, Treatment, and Care
Cancer is one of the leading causes of death in the US and China. Of the top 10 (by incidence) canc
ers in China, four are women’s cancers, including breast and cervical cancers.
+ Read More
report
Distance as an Obstacle to Clinical Trial Access: Who Is Affected and Why It Matters
Access to clinical trials is valuable for patients as it provides the possibility to obtain novel t
reatments that are not yet commercially available.
+ Read More
report
Employer Investments in Digital, Whole-Person Health for Substance Use Disorders
Employers seek to support their employees while normalizing a whole-person approach to substance us
e disorders (SUD). The response to addiction and the opioid crisis requires a whole-of-society approach, including employers of all sizes.
+ Read More
report
Toward a National Action Plan for Achieving Diversity in Clinical Trials
Participation in clinical research among racial and ethnic minorities remains low, even though such
groups now represent nearly 40 percent of the US population.
+ Read More
podcast episode
Ep. 68: Outcomes, with Helmsley Charitable Trust's David Panzirer
“The whole premise that where you live dictates your access to specialty care, dictates your outco
mes, dictates your access to tools to manage your disease.
+ Read More
podcast episode
Ep. 50: Special Edition — Potential Breakthroughs in COVID-19 Research Coming From Cancer Research
For our 50th recording, Jonathan Simons (President and CEO, Prostate Cancer Foundation) and Esther
Krofah (Executive Director, FasterCures) join Mike for a special discussion on how breakthroughs in cancer laboratories are advancing our understa
+ Read More